[Retracted] MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway
Affiliations: Department of Ophthalmology and Optometry, North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China, Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637100, P.R. China, Department of Ophthalmology, Yixing Eye Hospital, Yixing, Jiangsu 214200, P.R. China, Department of Ophthalmology, Suining Central Hospital, Suining, Sichuan 637000, P.R. China, Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China
- Published online on: August 18, 2022 https://doi.org/10.3892/or.2022.8389
- Article Number: 174
Copyright : © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Oncol Rep 43: [Related article:] 635–645, 2020; DOI: 10.3892/or.2020.7456
Following the publication of the above paper, it was drawn to the Editors' attention by a concerned reader that certain of the flow cytometric data featured in Figs. 2D, 4D and 5D, the colony formation assay data shown in Figs. 2C, 4C and 5C, and the tumor images shown in Fig. 7A were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article were already under consideration for publication, or had already been published, prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.